онкология и гериатрия

The cancer dairy железы now is most frequently meeting malignant новообразованием among women, with annually increasing parameters of desease [1]. Despite of the big popularity органосохраняющего treatments, his{its} application is limited to early stages of a cancer dairy железы with a tumour no more than 3 sm, absence clinically positive axillary лимфоузлов, the size dairy железы, localization of a tumour and a number{line} of other reasons [2]. The increase in number of local relapses and quite often unsatisfactory aesthetic results [3] also takes place. Also frequency of application органосохраняющего treatments depends on quality of diagnostics of early stages of disease in concrete medical institution. Therefore the basic type of radical intervention at a cancer dairy железы still is modified radical мастэктомия in updatings Маддена and a plenty of the patients who have transferred this operative мешательство, experience the significant psychological difficulties connected to loss dairy железы [4]. Подробнее...

1491 patient with a cancer has taken part in research BCRIG01 dairy железы with positive axillary лимфоузлами; middle age has made 49 years, 62 % of patients had from 1 up to 3 лимфоузлов, at 69 % of a tumour were рецепторопозитивными on РЭ and РП, at 20 % - positive on HER2/neu. All patients having positive РЭ and РП, received also тамоксифен in a doze of 20 mg / ЯТФ. Within 5 years. The median of time of supervision at the moment of the analysis of results has made 33 (0-49) months. Подробнее...